SAT0423 Patient-Reported Quality of Life in Patients with Baseline Objective Signs of Inflammation and Active Nonradiographic Axial Spondyloarthritis Treated with Golimumab: Results of The Open-Label Extension of A Randomized, Double-Blind Study

BackgroundIn a randomized, double-blind (DB), placebo (PBO)-controlled, phase 3 study (GO-AHEAD; NCT01453725), patients (pts) with nonradiographic axial spondyloarthritis (nr-axSpA) had significantly greater improvement in quality of life (QoL) after 16 weeks of treatment with golimumab (GLM) compar...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Annals of the rheumatic diseases 2016-06, Vol.75 (Suppl 2), p.824-824
Hauptverfasser:	Maksymowych, W.P., Dougados, M., Sieper, J., Braun, J., Bergman, G., Curtis, S.P., Tzontcheva, A., Philip, G., Huyck, S., van der Heijde, D.
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!